false
OasisLMS
Login
Catalog
Neurodiversity and Addiction (2025-2026 Recording)
Neurodiversity and Addiction Recording
Neurodiversity and Addiction Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
This lecture explored the relationship between neurodiversity—especially autism and ADHD—and addiction. Dr. Alisa Sikulski began with a case of a middle-aged woman who sought help for alcohol use and later was diagnosed with autism spectrum disorder (ASD). Using this case, she explained ASD diagnostic criteria, developmental onset, functional impairment, and the importance of recognizing masking/camouflaging behaviors, especially in adults.<br /><br />The talk highlighted that people with autism are not necessarily protected from substance use disorders (SUDs). In fact, while some traits may reduce exposure or appeal to substances, many individuals use alcohol, cannabis, nicotine, opioids, or stimulants to manage anxiety, sensory overload, or the exhaustion of masking. Shared neurobiology may include reward dysregulation, repetitive habit loops, and prefrontal executive dysfunction. She emphasized that screening tools can help, but diagnosis requires a full developmental history. Treatment should be individualized, sensory-informed, and flexible, with accommodations and family support when appropriate.<br /><br />The second half focused on ADHD and addiction through the case of a young woman using methamphetamine to self-treat longstanding inattention and fatigue. Dr. Sikulski reviewed adult ADHD presentation, differential diagnosis, and the strong overlap with SUDs. She stressed that ADHD must begin in childhood and affect multiple settings. Treating ADHD can improve substance-related outcomes, and current guidance supports long-acting stimulants when benefits outweigh risks, with careful monitoring. Non-stimulants are options for higher-risk patients. Psychosocial treatment, contingency management, and integrated care are essential.<br /><br />Overall, the key message was that clinicians should screen for neurodivergence in addiction settings, avoid assumptions, and tailor treatment to each patient’s lived experience.
Keywords
neurodiversity
autism spectrum disorder
ADHD
addiction
substance use disorder
masking
camouflaging
sensory overload
executive dysfunction
reward dysregulation
adult diagnosis
developmental history
stimulant treatment
contingency management
×
Please select your language
1
English